Marimed (MRMD) Non-Current Debt (2012 - 2026)
Marimed's (MRMD) quarterly Non-Current Debt came in at $173000.0 in Q1 2026, up 8.13% year-on-year from $160000.0 in Q1 2025, and down 6.49% on a QoQ basis from $185000.0 in Q4 2025.
Marimed (MRMD) Non-Current Debt (2012 - 2026) Analysis & Trends
Marimed (MRMD) has 14 years of Non-Current Debt data on file, last reported at $173000.0 in Q1 2026.
- On a quarterly basis, Non-Current Debt rose 8.13% year-over-year to $173000.0 in Q1 2026; TTM through Mar 2026 was $173000.0, a 8.13% increase from a year earlier, with the FY2025 full-year figure at $185000.0, up 3.93% from the prior year.
- Non-Current Debt for Q1 2026 stood at $173000.0, down from $185000.0 in the prior quarter.
- Over the last five years, Non-Current Debt for MRMD reached as high as $31.2 million in Q3 2023 and fell as low as $46000.0 in Q1 2022.
- Historically, Non-Current Debt has averaged $5.0 million across 5 years, with a median of $178000.0 in 2023.
- Across the five-year window, Non-Current Debt plunged 99.72% in 2022 and jumped 45123.91% in 2023, its largest moves.
- Year by year, Non-Current Debt stood at $48000.0 in 2022, then surged by 270.83% to $178000.0 in 2023, then changed by 0.0% to $178000.0 in 2024, then climbed by 3.93% to $185000.0 in 2025, then fell by 6.49% to $173000.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $173000.0 in Q1 2026, $185000.0 in Q4 2025, and $352000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 10.34 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 14.02 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 27.86 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 12.41 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.74 Bn |
| 10 | Marimed | 23.85 Mn | 14.02 Mn | 15.28 Mn | 173,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 173,000.00 |
| Dec 31, 2025 | 185,000.00 |
| Sep 30, 2025 | 352,000.00 |
| Jun 30, 2025 | 151,000.00 |
| Mar 31, 2025 | 160,000.00 |
| Dec 31, 2024 | 178,000.00 |
| Sep 30, 2024 | 177,000.00 |
| Jun 30, 2024 | 352,000.00 |
| Mar 31, 2024 | 148,000.00 |
| Dec 31, 2023 | 178,000.00 |
| Sep 30, 2023 | 31.18 Mn |
| Jun 30, 2023 | 20.55 Mn |
| Mar 31, 2023 | 20.80 Mn |
| Dec 31, 2022 | 48,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 17.26 Mn |
| Sep 30, 2021 | 925,871.00 |
| Jun 30, 2021 | 2.02 Mn |
| Mar 31, 2021 | 3.24 Mn |
| Dec 31, 2020 | 10.68 Mn |